Skip to main content
SpringerLink
Log in
SpringerLink
Log in

References

Literaturzitate

  • Chapter
Drug Epidemiology / Pharmako-Epidemiologie

  • 64 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References / Literaturzitate

  1. Abenhaim, L, Suissa, S., Introduction to Pharmacoepidemiology (II), McGill University, Department of Epidemiology and Biostatistics, Course 513–631, Annual Summer Programme, 1991

    Google Scholar 

  2. Abramson, J. H., Survey Methods in Community Medicine, — 4th ed., Churchill Livingstone, New York, 1990

    Google Scholar 

  3. Abramson, J. H., Making Sense of Data, Oxford University Press, New York, 1988

    Google Scholar 

  4. Abramson, J. H., Classification of Directionality in Epidemiologic Research, J. Clin. Epidemiol., 1989, 42, 819–820

    Article  PubMed  CAS  Google Scholar 

  5. Aday, L. A., Designing and Conducting Health Surveys, A Comprehensive Guide, Jossey-Bass Publihers, San Francisco, 1989

    Google Scholar 

  6. Ackermann-Liebrich, U., Gutzwiller, F., Keil, Kunze, M., Epidemiologie, Lehrbuch für praktizierende Ärzte und Studenten, 2nd. ed., Medication Foundation, Cham, Schweiz, 1990

    Google Scholar 

  7. Ahlbohm, A., Norell, S., Introduction to Modern Epidemiology. — 2nd ed. Epidemiology Resources Inc, Stockholm, 1990

    Google Scholar 

  8. Bode, C. Ph., Bergmann, K., Einführung in die moderne Epidemiologie, BGA Schriften [19] 91,2, MMV Medizin Verlag München, 1991

    Google Scholar 

  9. Anderson, S., Auquier, A., Hauck, W.W., Okes, D., Vandaele, W., Weisberg, H.I., Statistical Methods for Comparative Studies, Techniques for Bias Reduction, John Wiley & Sons, New York, 1980

    Book  Google Scholar 

  10. Armitage P., Berry, G., Statistical Methods in Medical Research, 2nd ed., Blackwell Scientific Publications, London, 1987

    Google Scholar 

  11. Bailar, J.C., Thomas, A.L., Lavori, P.W., Polansky, M., A Classification for Biomedical Research Reports, The New England Journal of Medicine, 1984, 311, 1482–1487

    Article  PubMed  Google Scholar 

  12. Bauer P., Biometrische Planung, in Grundlagen und Methoden von Arzneimittelprüfungen, in Ferber, H.P., Henschler, D., Hildebrandt, A.G., Kraupp, O., Lehnert, T., Schütz, W., Schulte-Hermann, R., Walter de Gruyter Verlag, Berlin, 1990

    Google Scholar 

  13. Bégaud, B., Evreux, J.C., Jouglard, J., Lagier, G. Unexpected or Toxic Drug Reaction Assessment (Imputation), Theapie, 1985, 40 111–118

    Google Scholar 

  14. Berkson, J., Limitations of the Application of Fourfold Table Analysis to Hospital Data, Biometrics Bull., 1946 (2), 47–53

    Google Scholar 

  15. Bethge H., Czechanowski, B., Gundert-Remy U., Hasford J., Kleinsorge, H., Kreutz, G., Letzel, H., Müller, A.A., Selbmann, H.K., Weber, E., Empfehlungen zur Ermittlung, Dokumentation, Erfassung und Bewertung unerwünschter Ereignisse im Rahmen der Klinischen Prüfung von Arzneimitteln, Arzneim.-Forsch./Drug Res., 1989, 39 (II), 10, 1294–1300

    Google Scholar 

  16. Bethge H., Czechanowski, B., Gundert-Remy U., Hasford J., Kleinsorge, H., Kreutz, G., Letzel, H., Müller, A.A., Selbmann, H.K., Weber, E., Recommendations for the Detection, Recording, Collection and Evaluation of Adverse Events in the Clinical Investigation of Drugs, Drugs made in Germany, 1991, 34 (1), 10–15

    Google Scholar 

  17. Bekanntmachung über die Anzeige von Nebenwirkungen, Wechselwirkungen mit anderen Mitteln und Arzneimittelmißbrauch nach § 29 Abs. 1 Satz 2–5 vom 25. Juli 1991, Bundes-gesundhbl. 1991 (10), 490–493

    Google Scholar 

  18. Bland, M., An Introduction to Medical Statistics, 1990, Oxford University Press

    Google Scholar 

  19. Blaschke, T.F., Pharmacokinetics and Pharmacoepidemiology, Scientific American Ind., 1986, 1–12 in [SPI 01, 256–261]

    Google Scholar 

  20. Boivin, J.-F., Department of Epidemiology and Biostatistics, McGill University, Montreal, Personal communication, 1992

    Google Scholar 

  21. Bortz J., Statistik für Sozialwissenschaftler, 1989, 3. Auflage, Springer Verlag Heidelberg

    Google Scholar 

  22. Bradford Hill, A., Statistical Evidence and Inference, in Principles of Medical Statistics. — 9th ed., Oxford University Press, 1971, 309–323

    Google Scholar 

  23. Bradford Hill, A., The Environment and Disease : Association or Causation, Proc. Roy. Soc. Med., 1965, (58), 295–300

    Google Scholar 

  24. Chui, R.C.-J., Mulder, D.S., Case Sudies for Learning Basic Biostatistical Concepts, in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, M.F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991, 144–150

    Google Scholar 

  25. CIOMS, International Reporting of Adverse Drug Reactions, Final Report of CIOMS Working Group, 1990, Council for International Organizations of Medical Sciences, Geneva

    Google Scholar 

  26. Cochrane A.L., Effectiveness and Efficiency, Random Reflections on Health Services, London, Nuffield Provincial Hospitals Trust, 1972

    Google Scholar 

  27. Colton, T., Statistics in Medicine. 1st-ed., Little Brown and Company, Boston, 1974

    Google Scholar 

  28. Cole, P., MacMahon, B., Attributable Risk Percent in Case-Control Studies, Brit. J.prev. soc. Med., 1971, 25, 242–244

    CAS  Google Scholar 

  29. Collet, J-P., Boissel, J-P., et al., Sick Population — Treated Population : The Need for a Better Definition, European Journal of Clinical Pharmacology, 1991, (41), 267–271

    Google Scholar 

  30. Cornfield, J., A Method of Estimating Comparative Rates from Clinical Data, Applications to Cancer of the Lung, Breast, and Cervix, Journal of the National Cancer Institute 1951, (11), 1269–1275

    PubMed  CAS  Google Scholar 

  31. Cornfield, J., Gorgon T., Smith W.W., Quantal Response Curves for Experimentally Uncontrolled Variables, Bulletin of the International Statistical Institute, 1961, (38), 97–115

    Google Scholar 

  32. Cornfield, J., Joint Dependence of Risk of Coronary Heart Disease on Serum Cholesterol and Systolic Blood Pressure, a Discriminant Function Analysis, Federation Proceedings, 1962, (21), 58–61

    Google Scholar 

  33. Coté, R.A. (ed.), Systematised Nomenclature of Medicine (SNOMED), Vol I, 2nd edition, College of American Pathologists, 1979, (Numeric index)

    Google Scholar 

  34. Coté, R.A. (ed.), Systematised Nomenclature of Medicine (SNOMED), vol II, 2nd edition, College of American Pathologists, 1979, (Alphebetic Index)

    Google Scholar 

  35. Coté, R.A. and Robboy, S., Progress in Medical Information Management. Systematised Nomenclature of Medicine (SNOMED), JAMA, 1980, 243, 756–762

    Article  PubMed  Google Scholar 

  36. Cox, D.R., Regression Models and Life-Tables, Journal of the Royal Statistical Society, Series B, 1972, (34), 187–202

    Google Scholar 

  37. Dawson-Saunders, B., Trapp, R.G., Basic and Clinical Biostatistic, 1990, Prentice Hall International

    Google Scholar 

  38. Koehler, K., Saß, H., Diagnostisches und Statistisches Manual DSM-III, Beltz

    Google Scholar 

  39. Drummond, M.F., Stoddart, G.L., Torrance G.W., Methods for the Economic Evaluation of Health Care Programmes, Oxford Medical Publications, Oxford, 1990

    Google Scholar 

  40. Duden, Wörterbuch medizinischer Fachausdrücke. -3. Auflage, Georg Thieme Verlag, Stuttgart, 1979

    Google Scholar 

  41. Der Grosse Duden, Fremdwörterbuch, Band 5, 3. Auflage 1974, Bibliographisches Institut Mannheim; Dudenverlag

    Google Scholar 

  42. Duden, Deutsches Universalwörterbuch A-Z, 1989, Bibliographisches Institut Mannheim; Dudenverlag

    Google Scholar 

  43. Edwards, R., Linquist, M., Wiholm, B.E., Napke, E., Quality Criteria for Early Signals of Possible Adverse Drug Reactions, Lancet, 1190, 336, 156–158

    Article  Google Scholar 

  44. Eisenberg, J.M., Glick, H., Koffer, H., Pharmacoeconomics: Economic Evaluation of Pharmaceuticals, in Brian L. Strom, Pharmacoepidemiology, 1989, Churchill Livingstone, New York

    Google Scholar 

  45. Elandt-Johnson, R., Definition of Rates : Some Remarks on Their Use and Misuse, Am. J. of Epidemiol., 1975, 102, 267–271

    CAS  Google Scholar 

  46. Costart, Coding Symbols for Thesaurus of Adverse Reaction Terms. — 3th ed., Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Epidemiology and Biostatistics, 1989

    Google Scholar 

  47. Guideline for Postmarketing Reporting of Adverse Drug Reactions [Docet No. 850–0249], Department of Health and Human Services, Food and Drug Administration, Center for Drug and Biological Products Experience, Center for Drugs and Biologics, 1985

    Google Scholar 

  48. Feinstein, Alvan, R., Clinical Epidemiology, the Architecture of Clinical Research, 1985, W.B. Saunders Company, Philadelphia

    Google Scholar 

  49. Feinstein, Alvan, R., Directionality in Epidemiologic Research, J. Clin. Epidemiol, 1988, 705–707

    Google Scholar 

  50. Feinstein, Alvan, R., Directionality and Scientific Inference, J. Clin. Epidemiol, 1989, 829–833

    Google Scholar 

  51. Ferner, H.P., Henschler, D., Hildebrandt, A.G., Kraupp, O., Lehnert, T., Schütz, W., Schulte-Hermann, R., Grundlagen und Methoden von Arznei mittelprüfungen, Walter de Gruyter, Berlin, 1990

    Google Scholar 

  52. Fleiss, J.L., Statistical Methods for Rates and Proportions, 2nd ed. 1981, John Wiley & Sons, Inc., New York

    Google Scholar 

  53. Frentzel-Beyme, R., Einführung in die Epidemiologie, Wissenschaftliche Buchgesellschaft Darmstadt, 1985

    Google Scholar 

  54. Freund, J.E., Mathematical Statistics, 2nd ed., Prentice-Hall, INC., Englewood Cliffs, New Jersey, 1971

    Google Scholar 

  55. Friedman, G.D., Primer of Epidemiology, 1987, McGraw-Hill Book Company

    Google Scholar 

  56. Friedman, L.M., Furberg, C.D., DeMets, D.L., Fundamentals of Clinical Trials, 2nd ed., Mosby Year Book, St. Louis, 1985

    Google Scholar 

  57. Gehan, E.A., Estimating Survival Functions from the Life Table, J. Chron. Dis., 1969, 21, 629–644

    Article  PubMed  CAS  Google Scholar 

  58. Glass, G.V., Primary, Secondary, and Meta-Analysis of Research, Educational Research, 1976(5), 3–8

    Google Scholar 

  59. Deutsche Gesellschaft für Medizinische Dokumentation, Informatik und Statistik e.V. (GMDS), Wichmann, H.E., Lehmacher, W. Manual für die Planung und Durchführung epidemiologischer Studien, 1991, Schattauer, Stuttgart

    Google Scholar 

  60. Gordon, V.C., Wierenga, D.E., The Drug Development and Approval Process, in Development New Medicines for Women, Pharmaceutical Manufactures Association, 1991

    Google Scholar 

  61. Greenland, S., Morgenstern, H., Classification Schemes for Epidemiologic Research Designs, J. Clin Epidemiol., 1988, 41, 715–716

    Article  PubMed  CAS  Google Scholar 

  62. Guggenmoos-Holzmann, I., Einführung in die Prinzipien und Methoden der Biostatistik, Kurs WS 1993/94, personal communication

    Google Scholar 

  63. Gundert-Remy, U., Schmidlin, O., Schroeder, H., Einführung in die Klinische Pharmakologie, Springer Verlag Heidelberg, 1983

    Book  Google Scholar 

  64. Gundert-Remy, U., Klinische Prüfung von Arzneimitteln, Med. Mo. Pharm. 1982, 5, 266–268

    CAS  Google Scholar 

  65. Haberman, S., Mathematical Treatment of the Incidence and Prevalence of Disease, Social Sci & Med., 1978, 12, 147–152

    Article  CAS  Google Scholar 

  66. Hamilton, M.A., Choosing the Parameter for a 2X2 Table or a 2X2X2 Table Analysis, Am. J. of Epidemiol., 1979, 109, 362–375

    CAS  Google Scholar 

  67. Hanley, James, H., Lippman-Hand, A., If Nothing goes wrong, is Everything All Right, Interpreting Zero Numerators, JAMA, 1983, 249, (13) 1743–1745

    Article  PubMed  CAS  Google Scholar 

  68. Hanley, J. H., Principles of Inferential Statistics in Medicine, McGill University, Department of Epidemiology and Biostatistics, Course 513–631, Annual Sommer Program, 1991

    Google Scholar 

  69. Harms, V., Biomathematik, Statistik und Dokumentation. — 5th ed., Harms Verlag Kiel, 1988

    Google Scholar 

  70. Hennekens, C.H., Buring, J., Epidemiology in Medicine, 1987, Little Brown and Company, Boston, Toronto

    Google Scholar 

  71. Pharmacoepidemiology Glossary, in A.G. Hartzema, M.S. Porta, H.H. Tilson, Pharmacoepidemiology : An Introduction, Harvey Whitney Books, 1988

    Google Scholar 

  72. Porta, M.S., Hartzema, A.G., Tilson, H.H., Pharmacoepidemiology : An Introduction, 2nd ed., Harvey Whitney Books, 1991

    Google Scholar 

  73. Hutchinson, T.A., Lane, D.A., Standardized Methods of Causality Assessment for suspected adverse Drug Reactions, J. Chron. Dis., 1986, 39, 857–860

    Article  PubMed  CAS  Google Scholar 

  74. Huth, E., Medical Style & Format : An Introduction, 1987

    Google Scholar 

  75. Handbuch der Internationalen Klassifikation der Krankheiten, Verletzungen und Todesursachen (ICD) 1979

    Google Scholar 

  76. Braun, R., Diekmann, F., ICD Ziele und Veränderungen der 10. Revision, PMD, 1991, 11, 58–62

    Google Scholar 

  77. Inman, W.H.W., Postmarketing Surveillance of Adverse Drug Reactions in General Practice I, British Medical Journal, 1981, 282, 1131–1132

    Article  PubMed  CAS  Google Scholar 

  78. Inman, W.H.W., Postmarketing Surveillance of Adverse Drug Reactions in General Practice, II, British Medical Journal, 1981, 282, 1216–1217

    Article  PubMed  CAS  Google Scholar 

  79. Jones, J.K., A Bayesian Approach to Causality Assessment, Psychopharmacology Bulletin, 1987, 23, (3), 395–399

    PubMed  CAS  Google Scholar 

  80. Kark, S.L., Epidemiology and Community Medicines, Appleton-Century-crofts, New York, 1974

    Google Scholar 

  81. Karch, F.E., Lasagna, L, Adverse Drug Reactions, JAMA, 1975, 234 (12), 1236–1241

    Article  PubMed  CAS  Google Scholar 

  82. Kelsey J.L., Thompson, D.W., Methods in Observational Epidemiology, Oxford University Press, New York, 1986

    Google Scholar 

  83. Kleinbaum, D.L., Kupper, L.L., Morgenstern, H., Epidemiologic Research, Principles and Methods, Van Nostrand Reinhold, New York, 1982

    Google Scholar 

  84. Kramer, M.S., Clinical Epidemiology and Biostatistics, A Primer for Clinical Investigators and Decision Makers, Springer Verlag Heidelberg, 1988

    Google Scholar 

  85. Kramer, M.S., Clinical Biostatistics : An Overview, in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, M.F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991

    Google Scholar 

  86. Kramer, M.S., Boivin, J.-F., Toward an “Unconfounded” Classification of Epidemiologic Research Design, Journal of Chronic Diseases 1987, 40, 683–688

    Article  PubMed  CAS  Google Scholar 

  87. Responses : Importance of Directionality in Epidemiolgic Research Design, Journal of Clinical Epidemiology 1988, 41, 717–718

    Google Scholar 

  88. Responses : Directionality, Timing, and Sample Selection in Epidemiologic Research Design, Journal of Clinical Epidemiology 1989, 42, 827–828

    Google Scholar 

  89. Kullmann, H.J., Die Haftungsregelung des §84 AMG, Pharmarecht, 1981 (4), 112–119

    Google Scholar 

  90. Kupper, L.L., Hogan, Interaction in Epidemiologic Studies, American Journal of Epidemiology 1978, 108, 447–453

    PubMed  CAS  Google Scholar 

  91. Lane, D. A., The Bayesian Approach to Causality Assessment : An Introduction, 1986, 20, Drug Information Journal, 455–461

    Google Scholar 

  92. Lane, D. A., Kramer, M.S., Hutchinson, M.B., Lane, D.A., Jones, J., Naranjo, C., The Causality Assessment of Adverse Drug Reactions Using a Bayesian Approach, Pharmaceutical Medicine, 1987, 2, 265–283

    Google Scholar 

  93. Kramer, M.S., Hutchinson, M.B., Lane, D.A., Jones, J., Naranjo, C., The Bayesian Approach to Causality Assessment for Adverse Drug Reactions, 1986, 20, Drug Information Journal, 523–533

    Google Scholar 

  94. Last, J.M., A Dictionary of Epidemiology. — 2nd ed. Oxford University Press, 1988

    Google Scholar 

  95. Levine, M.L., The Occurrence of Lung Cancer in Man, Acta Unio International Contra Cancrum, 1953, (9), 531–541

    Google Scholar 

  96. Lilienfeld, A.M., Foundations of Epidemiology, 2nd ed., New York, Oxford University Press, 1980

    Google Scholar 

  97. Lilienfeld, D.E., Definitions of Epidemiology, American Journal of Epidemiology, 1978, 107, 87–90

    PubMed  CAS  Google Scholar 

  98. Louis T.A., Shapiro S.H., Critical Issues in the Conduct and Interpretation of Clinical Trials, Annual Review of Public Health, 1983 (43), 25–46

    Article  Google Scholar 

  99. MacMahon, B., Pugh, T., Epidemiology, Principles and Methods, Little Brown and Company, 1970

    Google Scholar 

  100. Mausner J.S., Kramer S., Epidemiology, an Introductory Text, 2nd ed., W.B. Saunders Company, Philadelphia, 1985,

    Google Scholar 

  101. McPeek B., Mosteller, F., McKneally, M.F:, Neugebauer, E.A.M., Experimental Methods: Clinical Trials, in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, M.F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991, 114

    Google Scholar 

  102. Mechanic D., The Concept of Illness Behavior, Journal of Chronic Diseases, 1962, (15), 189–194

    Article  PubMed  CAS  Google Scholar 

  103. Miettinen, O.S., Estimability and Estimation in Case-Referent Studies, Am. J. Epidemiol., 1976, 103, (2), 226–235

    PubMed  CAS  Google Scholar 

  104. Miettinen, O.S., The “Case-Control” Study: Valid Selection of Subjects, J. Chron. Dis., 1985, 38, 543–548

    Article  PubMed  CAS  Google Scholar 

  105. Miettinen, O.S., Caro, J.J, Principles of Nonexperimental Assessment of Excess Risk, with Special Reference to Adverse Drug Reactions, J. Clin. Epidemiol., 1989, 42, 325–331

    Article  PubMed  CAS  Google Scholar 

  106. Miettinen, O.S., Striving to Deconfound the Fundamentals of Epidemiologic Study Design, J. Clin. Epidemiol., 1988, 41, 709–713

    Article  PubMed  CAS  Google Scholar 

  107. Miettinen, O.S., Confounding and Effect Modification, Am. J. Epidemiol., 1974, 100 350–353

    PubMed  CAS  Google Scholar 

  108. Miettinen, O.S., Proportion of Disease Caused or Prevented by a Given Exposure Trait or Intervention, American Journal of Epidemiology, 1974, (99), 325–332

    PubMed  CAS  Google Scholar 

  109. Miettinen, O.S., Theoretical Epidemiology, Principles of Occurrence Research in Medicine, John Wiley & Sons, 1985, New York

    Google Scholar 

  110. Moore, D.S., McCabe, G.P., Introduction to the Practice of Statistics, W.H. Freeman and Company, New York, 1989

    Google Scholar 

  111. MacMahon, B., and Pugh, T.F. Epidemiology : Principles and Methods, Little Brown Boston, 1970

    Google Scholar 

  112. Monson, R.R., Occupational Epidemiology, 2nd ed., CPC Press, Inc., 1990

    Google Scholar 

  113. Morgenstern, H., Kleinbaum, D.G., Kupper, L.L., Measures of Disease Incidence Used in Epidemiology Research, Int. J. Epidemiol. 1980, 9, 97–104

    Article  PubMed  CAS  Google Scholar 

  114. Naranjo, C.A., A Bayesian Approach to Assessment of Adverse Drug Reactions: Evaluation of a Case of Cholestatic Jaundice, Drug Information Journal, 1986, 20, 465–471

    Google Scholar 

  115. National Library of Medicine, Bethesda, Medical Subject Headings (Mesh), Annotated Alphabethical List, 1986

    Google Scholar 

  116. Troidl, H., Spitzer, W.O., Mulder, D.S., Wechsler, A.S., McPeek, B., McKneally, F., Balch, C.M. Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991

    Google Scholar 

  117. Rasch, D., Biometrisches Wörterbuch. — 3rd ed., VEB Deutscher Landwirtschaftsverlag, DDR-Berlin, 1987

    Google Scholar 

  118. Rawlins, M.D., and Thompson, J.W., Pathogenesis of Adverse Drug Reactions, in Adverse Drug Reactions, M. Davies, Oxford University Press, 1977, 10–31

    Google Scholar 

  119. Rawlins, M.D., Frachhia, G.N., Rodriguez-Farré, E., EURO-ADR : Pharmacovigilance and Research, an European Perspective, Pharmacoepidemiology and Drug Safety, 1992, (1), 261–268

    Article  Google Scholar 

  120. Roberts, R.S., Spitzer, W.O., Delmore T., Sackett, D.L., Admission Rate (Berkson’s) Bias, 1978, (31), 119–128

    CAS  Google Scholar 

  121. Roche, Lexikon Medizin, Urban & Schwarzenberg, München, 1984

    Google Scholar 

  122. Rothman, K. J., Modern Epiddemiology, Little Brown and Company, Boston, Toronto, 1986

    Google Scholar 

  123. Rothman, K. J., Synergy and Antagonism in Cause-Effect Relationships, Am. J. Epidemiol. 1974, 99, 385–388

    PubMed  CAS  Google Scholar 

  124. Rothman, K. J., Greenland, S., Walker, A.M., Concepts of Interaction, Am. J. Epidemiol., 1980, 112, 467–470

    PubMed  CAS  Google Scholar 

  125. Rothman, K. J., Induction and Latent Periods, Am. J. Epidemiol. 1981, 114, 252–259

    Google Scholar 

  126. Rümke, C.L., Implication of the Statement : No Side Effects Were Observed, New England Journal of Medicine, 1975, 292, 372–373

    PubMed  Google Scholar 

  127. Rümke, C.L., Uncertainty as to the Acceptance or Rejection of Presence of an Effect in Relation to the Number of Observations in an Experiment, Triangle, 1968, 8, 284–289

    PubMed  Google Scholar 

  128. Sachs, L., Statistische Methoden : Planung und Auswertung, -6th ed., 1988, Springer Verlag, Heidelberg

    Google Scholar 

  129. Sachs, L., Statistische Methoden 2 : Planung und Auswertung, Springer Verlag Heidelberg, 1990

    Book  Google Scholar 

  130. Sackett, D. L., Bias in Analytic Research, J. Chron. Dis., 1979, (32), 51–63

    Article  PubMed  CAS  Google Scholar 

  131. Sachs, L., Angewandte Statistik, 7. Auflage, 1992, Springer Verlag, Heidelberg

    Google Scholar 

  132. Sackett, D.L., Gent, Controversy in Counting and Attributing Events in Clinical Trials, New England Journal of Medicine, 1979, (301), 1410–1412

    Article  PubMed  CAS  Google Scholar 

  133. Schechter, M.T., Evaluation of the Diagnostic Process, in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, M.F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991

    Google Scholar 

  134. Schechter, M.T., F.E. LeBlanc, and V.A. Lawrence, Critical Appraisal of Published Research, in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, .F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991

    Google Scholar 

  135. Schochtholt, J., ATC Classification and Defined Daily Dose : Significance and Limitations, Pharm. Ind. 1991, 53, 1007–1079

    Google Scholar 

  136. Schlesselman, J.J., Case-control Studies : Design, Conduct, Analysis, New York, Oxford University Press

    Google Scholar 

  137. Schäfer, M., personal communication

    Google Scholar 

  138. Schwartz D., Lellouch J., Explanatory and Pragmatic Attitudes in Therapeutic Trials, Journal of Chronic Diseases, 1967, (20), 637–648

    Article  PubMed  CAS  Google Scholar 

  139. Shapiro, H.S., Louis, T.A., Clinical Trials, Issues and Approaches, 1983, Marcel Dekker, Inc. New York

    Google Scholar 

  140. Sickmüller, B., Bestimmungen zur Anzeige von Nebenwirkungen, Pharm. Ind. 1988, (50)

    Google Scholar 

  141. Sills, J.M., Tanner, L.A, Milstein, J.B., Food and Drug Administration Monitoring of Adverse Drug Reactions, Am. J. Hosp. Pharm., 1986, 43, 2764–2270

    PubMed  CAS  Google Scholar 

  142. Sills, J.M., Faich, G. A., Milstein, J.B., Turner, W.M., Postmarketing Reporting on Adverse Drug Reactions to the FDA : An Overview of the 1985 FDA Guidelines, Drug Information Journal, 1986, 151–156

    Google Scholar 

  143. Slavin, R.E., Best Evidence Synthesis : An ALternative to Meta-Analytic and Traditional Reviews, Educational Researcher, 1986, 15, 5–11

    Google Scholar 

  144. Spitzer, W.O., Horwitz, S.M., Selected Nonexperimental Methods : An Orientation, in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, M.F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991, 104–113

    Google Scholar 

  145. Spitzer, W.O., Boivin, J.-F., Introduction to Pharmacoepidemiology (I), Department of Epidemiology and Biostatistics, McGill University, Course 513–633C, Annual Sommer Program, 1991

    Google Scholar 

  146. Spitzer, W.O. et al. Links between Passive Smoking and Disease : A Best Evidence Synthesis, A Report of the Working Group on Passive Smoking, Clinical and Investigative Medicine, 1990, 13, 17–42

    PubMed  CAS  Google Scholar 

  147. Spitzer, W.O., Drugs as Determinants of Health and Disease in the Population : An Orientation to the Bridge Science of Pharmacoepidemiology, J. Clin. Epidemiol. 1991, 44, 823–830

    Article  PubMed  CAS  Google Scholar 

  148. Stephens, M.D.B., The Detection of New Adverse Drug Reactions.- 2nd ed., Stockton Press, New York, 1988

    Google Scholar 

  149. Strom, B.L., Pharmacoepidemiology, Churchill Livingstone, New York, 1989

    Google Scholar 

  150. Strom, B., Carson, J.L., Use of Automated Databases for Pharmacoepidemiology Research, Epidemiological Reviews, 1990, 87–107

    Google Scholar 

  151. Suissa, S., Statistical Methods in Pharmacoepidemiology, Principles in Managing Error, Drug Safety, 1991, 6, (5), 381–389

    Article  PubMed  CAS  Google Scholar 

  152. Suissa, S., Department of Epidemiology and Biostatistics, McGill University, Extention Course of Pharmacoepidemiology, Staßburg, 1990

    Google Scholar 

  153. Suissa, S., Department of Epidemiology and Biostatistics, McGill University, Personal Communication, 1992

    Google Scholar 

  154. Susser, M.W., Watson W., Hopper K., Sociology in Medicine, 3rd ed. New York, Oxford University Press, 1985

    Google Scholar 

  155. Venulet, J., Berneker, G.C., Ciucci, A.G., Assessing Causes of Adverse Drug R eactions with Special Reference to Standardized Methods, Academic Press, London, 1982

    Google Scholar 

  156. Wahrendorf, J., Methods of Age Adjustment, Recent Results in Cancer Research, 1989, (114), 64–69

    Article  PubMed  CAS  Google Scholar 

  157. Wahrendorf, J., personal communication

    Google Scholar 

  158. Walker, A. M., Observation and Inference, Epidemiology Resources Inc., Chestnut Hill, 1991

    Google Scholar 

  159. Webster’s Encyclopedic Unaridged Dictionary of the English Language, 1989, Portland House, New York

    Google Scholar 

  160. Webster’s Dictionary Including Thesaurus of Synonyms, Antonyms, 1992, Pamco Publishing Company, Inc., New York

    Google Scholar 

  161. WHO Technical Report No 498, 1972

    Google Scholar 

  162. International Monitoring of Adverse Reactions to Drugs, Adverse Reaction Terminology, WHO Collaborating Centre for International Drug Monitoring, 1989

    Google Scholar 

  163. WHO Collaborating Centre for International Drug Monitoring, Definitions — after Consulting with National Centres, in Press, 1991

    Google Scholar 

  164. WHO Bulletin, 1966, 35, 783 – 784, Prevalence and Incidence

    Google Scholar 

  165. WHO Technical Report No. 516, 1973, Youth and Drugs

    Google Scholar 

  166. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for DDD, Oslo, Norway, 1991

    Google Scholar 

  167. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification, Oslo, Norway, 1990

    Google Scholar 

  168. WHO International Classification of Disease, Manual of the International Statistics Classification of Diseases, Injuries and Causes of Death, vols 1 and 2, Alphabethical Index, 9th Revision, 1975

    Google Scholar 

  169. WHO : The selection of essential drugs, Report of a WHO Expert Committee, Geneva, Technical Repoert, 1977, Ser. No. 615

    Google Scholar 

  170. Constitution of the World Health Organization, 1948, In Basic Documents, 15th ed., WHO, Geneva, 1964

    Google Scholar 

  171. Wood-Dauphinée, S., Troidl, H., Endpoints for Clinical Studies : Conventional and Innovative Variables in H. Troidl, W.O. Spitzer, D.S. Mulder, A.S. Wechsler, B. McPeek, M.F. McKneally, C.M. Balch, Principles and Practice of Research. — 2nd ed., Springer Verlag, New York, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bundesgesundheitsamt Berlin, Bundesrepublik Deutschland

    Annekarin Bertelsmann (Apothekerin und Diplom Epidemiologin (McGill), Wissenchaftlich Direktorin)

Authors
  1. Annekarin Bertelsmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bertelsmann, A. (1993). References. In: Drug Epidemiology / Pharmako-Epidemiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78713-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78713-3_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-57560-3

  • Online ISBN: 978-3-642-78713-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation